Pfizer Eyes $20 Billion Revenue From Acquisitions Amid Patent Cliff Challenges

1. Pfizer implemented transformative changes, improving its commercial strategy. 2. Achieved $4 billion in savings and plans $1.5 billion margin improvements. 3. Facing $17-18 billion revenue loss due to exclusivity loss from 2025-2028. 4. Projected $20 billion revenue from acquired products by 2030. 5. Cautious 2024 guidance reflects uncertainty in COVID-19 revenue streams.